HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. by Daniel P. Bradley (10306893)

Co-transformed cells grow preferentially as tumors in peritoneal cavities. by Mitchell Hayes (5334887)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. by Daniel P. Bradley (10306893)

Changes in the genotypes of <i>NLRP1</i>, <i>NLRP3</i>, and <i>NLRP4</i>. by Hao Deng (409186)

Subjects:

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

Subjects:

Effect of the interaction of drinking, smoking and <i>ERCC1</i> rs3212986 on workers exposed to coal dust. by Hao Deng (409186)

Subjects:

Regression model analysis of the influence of <i>ERCC1</i> rs3212986 on CWP. by Hao Deng (409186)

Subjects:

Pathways analysis of ERCC1 based on CWP metabolome and proteome. by Hao Deng (409186)

Subjects:

Analysis of basic clinical data of the study population (± s). by Hao Deng (409186)

Subjects:

ROC curve analysis for ERCC1 with CWP progression. by Hao Deng (409186)

Subjects:

Change in the ERCC1 secretion level in plasma(pg/ml). by Hao Deng (409186)

Subjects:

S1 Data - by Hao Deng (409186)

Subjects:

Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

Subjects:

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Subjects:

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Subjects:

Relative frequency of type I (dark gray) and type II (light gray) errors in 10 000 replicas for each initial condition of the simulation. by Farrokh Habibzadeh (12256529)

Subjects:

PVS_ratio changes, ΔPVS_ratio, for different radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). by Ruitian Song (11045127)

Subjects: